Dronabinol (Therapix Biosciences)

屈大麻酚 (Therapix Biosciences)

Report date: 2025/03/07 13:43:17

Base Information

Drug NameDronabinol (Therapix Biosciences)
Drug Alias NameTHX-130
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonistsCannabinoid CB1 receptor agonists
TargetsCannabinoid CB2 receptorCannabinoid CB1 receptor
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTherapix Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTherapix Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsCognition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A